gnitive decline. A Congressional investigation later found that Biogen executives met with FDA officials including Dr. Billy Dunn, head of the neuroscience office dozens of times and inappropriately collaborated on a key regulatory document. Dunn did not respond to questions from The Times.
Date: Feb 14, 2024
Category: Health
Source: Google
Editorial: Don't fall for the 'big lie' about city safety | Dorchester Reporter
Whatever Billy Dunn and his compatriots thought they were doing right it didnt work. In 1990, there were 152 people murdered within city limits, a large number of them here in Dorchester. Teenagers were dying at an alarming rate. People who werent alive then or hadnt yet moved to this neighborhHaydens right. Its also important to push back against the cynical mythology spun by the Billy Dunns of the world, who want everyone to think modern-day Boston is being run into the ground by the people in charge today. The fact that the men and women who are running the city now are largely Black
Date: Jan 17, 2024
Category: Your local news
Source: Google
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients
For the first time, we have an FDA-approved treatment specifically for children and adolescents with multiple sclerosis, said Billy Dunn, M.D., director of the Division of Neurology Products in the FDAs Center for Drug Evaluation and Research. Multiple sclerosis can have a profound impact on a c
Date: May 11, 2018
Category: Health
Source: Google
MS Patient's Pick of the Week's News: Ocrevus and Its Approval, Reactions, Development
Billy Dunn, MD, director of the Division of Neurology Products in the FDAs Center for Drug Evaluation and Research, said in theFDAs officialrelease: Multiple sclerosis can have a profound impact on a persons life. This therapy not only provides another treatment option for those with relapsing
Multiple sclerosis can have a profound impact on a persons life, said Billy Dunn, M.D., director of the Division of Neurology Products in the FDAs Center for Drug Evaluation and Research. This therapy not only provides another treatment option for those with relapsing MS, but for the first time
Date: Mar 29, 2017
Category: Health
Source: Google
FDA approves 1st drug for aggressive multiple sclerosis
"This therapy not only provides another treatment option for those with relapsing MS, but for the first time provides an approved therapy for those with primary progressive MS," Dr. Billy Dunn, director of the FDA's Division of Neurology Products, said in a statement.
Date: Mar 29, 2017
Category: Health
Source: Google
FDA approves drug to treat Duchenne muscular dystrophy
This is the first treatment approved for a wide range of patients with Duchenne muscular dystrophy, said Billy Dunn, M.D., director of the Division of Neurology Products in the FDAs Center for Drug Evaluation and Research. We hope that this treatment option will benefit many patients with DMD.
Date: Feb 09, 2017
Category: Health
Source: Google
New drug to address unmet medical needs for fatal genetic disease
There has been a long-standing need for a treatment for spinal muscular atrophy, the most common genetic cause of death in infants, and a disease that can affect people at any stage of life, said Billy Dunn, M.D., director of the Division of Neurology Products in the FDAs Center for Drug Evaluati